HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Stock analysts at Northland Capmk dropped their Q3 2025 earnings per share estimates for HIVE Blockchain Technologies in a research note issued on Wednesday, December 4th. Northland Capmk analyst M. Grondahl now anticipates that the company will post earnings per share of ($0.14) for the quarter, down from their previous estimate of ($0.08). Northland Capmk currently has a “Strong-Buy” rating on the stock. Northland Capmk also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS, FY2025 earnings at ($0.46) EPS and Q1 2026 earnings at ($0.06) EPS.
HIV has been the subject of a number of other reports. HC Wainwright upgraded HIVE Blockchain Technologies from a “hold” rating to a “strong-buy” rating in a report on Thursday, August 15th. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a report on Tuesday, October 29th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Featured Articles
- Five stocks we like better than HIVE Blockchain Technologies
- How Investors Can Find the Best Cheap Dividend Stocks
- 10 Safe Investments with High Returns
- What is the Euro STOXX 50 Index?
- 3 Utility Stocks That Will Benefit from Less Regulation
- How Can Investors Benefit From After-Hours Trading
- AeroVironment Dives Into a Buying Opportunity
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
